BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2273487)

  • 1. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis.
    Dupuis LL; Koren G; Shore A; Silverman ED; Laxer RM
    J Rheumatol; 1990 Nov; 17(11):1469-73. PubMed ID: 2273487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis.
    Wallace CA; Smith AL; Sherry DD
    J Rheumatol; 1993 Oct; 20(10):1764-8. PubMed ID: 8295192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
    Kremer JM; Hamilton RA
    J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methotrexate and non-steroidal anti-inflammatory agent combination in rheumatoid arthritis].
    Bertin P; Carpentier N; Vergne P; Bonnet C; Bannwarth B; Dehais J; Treves R
    Therapie; 1997; 52(2):133-7. PubMed ID: 9231508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin is not associated with more toxicity than other nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis treated with methotrexate.
    Rooney TW; Furst DE; Koehnke R; Burmeister L
    J Rheumatol; 1993 Aug; 20(8):1297-302. PubMed ID: 8230008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.
    Skeith KJ; Russell AS; Jamali F; Coates J; Friedman H
    J Rheumatol; 1990 Aug; 17(8):1008-10. PubMed ID: 2213774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis.
    Ravelli A; Di Fuccia G; Molinaro M; Ramenghi B; Zonta L; Regazzi MB; Martini A
    J Rheumatol; 1993 Sep; 20(9):1573-7. PubMed ID: 8164218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
    Brik R
    Harefuah; 1998 Dec; 135(11):509-11, 567. PubMed ID: 10911466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of food on the bioavailability of oral methotrexate in children.
    Dupuis LL; Koren G; Silverman ED; Laxer RM
    J Rheumatol; 1995 Aug; 22(8):1570-3. PubMed ID: 7473485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing length of time taking methotrexate in rheumatoid arthritis.
    Ortendahl M; Schettler JD; Fries JF
    J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever in adult onset Still's disease. Response to methotrexate.
    Kraus A; Alarcón-Segovia D
    J Rheumatol; 1991 Jun; 18(6):918-20. PubMed ID: 1895278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
    Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
    J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ; Beal J; Day RO; Tett SE
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
    Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
    Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.